Harbor-UCLA Medical Center
Harbor-UCLA Medical Center
Torrance, California, United States10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy | cardiovascular disorder, heart disorder, heart failure | Recruiting | Phase 2 | 2026-10-05 | NCT06979362 | |
| Starting Technology in At Risk Type 1 Diabetes Study | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Not applicable | 2026-09-25 | NCT06453928 | |
| The PIONEER Comparative Effectiveness Study - Project 2 | Brain Concussion, Brain Injuries, Traumatic, Craniocerebral Trauma, Disease Attributes, Emergencies, Head Injuries, Closed, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Wounds, Nonpenetrating, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injury | Not yet recruiting | Not applicable | 2026-09-22 | NCT07829107 | |
| Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT) | Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Status Epilepticus, nervous system disorder, visual epilepsy | Recruiting | Phase 3 | 2026-09-17 | NCT06907173 | |
| A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease | Recruiting | Phase 3 | 2026-09-17 | NCT06612268 | |
| Decellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry | Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic kidney disease, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorder | Recruiting | Not stated | 2026-09-15 | NCT05880537 | |
| XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thyroid Cancer, Papillary, adenocarcinoma, carcinoma, endocrine system disorder, epithelial neoplasm, malignant endocrine neoplasm, neoplasm, papillary adenocarcinoma, thyroid gland disorder, thyroid gland follicular carcinoma, thyroid tumor | Recruiting | Phase 2 | 2026-06-26 | NCT06959641 | |
| Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care) | Chemically-Induced Disorders, Substance Use, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-05-07 | NCT06116266 | |
| A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Incontinence, Urinary Incontinence, Stress, Urinary Incontinence, Urge, Urination Disorders, Urogenital Diseases, Urological Manifestations, overactive bladder, urinary bladder disorder, urinary system disorder | Active, not recruiting | Not applicable | 2026-03-13 | NCT05534412 | |
| SELUTION SLR™ 014 In-stent Restenosis | cardiovascular disorder, coronary artery disorder, coronary restenosis, coronary stenosis, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2025-12-17 | NCT04280029 |